International Immunology · 2009 · 28 citations · 32 references
Life SciencesCell BiologyImmunologyImmunoregulationImmunotherapyTransplant ImmunologyGraft RejectionT Cell DifferentiationT Cell ToleranceTransplant ImmunotherapyTransplant RejectionTransplant ToleranceAllogeneic Skin GraftsCd4 Positive T CellsGraft Immunologic ToleranceNaive T CellsNatural Regulatory T CellsSkin GraftsTransplant Tolerance MechanismsTransplantation
Donor‑specific graft tolerance can be induced by allo‑antigen exposure combined with T‑cell modulation, such as donor‑specific transfusion with a non‑depleting anti‑CD4 monoclonal antibody, yet the cellular mechanisms remain unclear. In T‑cell–deficient BALB/c nude mice reconstituted with naive T cells, donor‑specific transfusion plus anti‑CD4 mAb induces tolerance to DBA/2 skin grafts, whereas depletion of Foxp3⁺CD25⁺CD4⁺ regulatory T cells abolishes this effect; the treatment selectively blocks expansion of allo‑antigen–specific CD4⁺ non‑regulatory T cells while sparing regulatory T cells, leading to Treg dominance and donor‑specific tolerance—a key mechanism that may underlie dominant transplantation tolerance.
Donor-specific graft tolerance can be established by a combination of allo-antigen exposure and manipulation of T cell function, for example by donor-specific transfusion (DST) under the cover of a non-depleting anti-CD4 mAb. Yet, the cellular basis of this graft tolerance is still obscure. This report shows that T cell-deficient BALB/c nude mice reconstituted with naive unfractionated T cells are specifically tolerized to DBA/2 skin grafts by DST and anti-CD4 mAb treatment, whereas those transferred with T cell suspensions depleted of all Foxp3+CD25+CD4+ natural regulatory T cells (Tregs) are not. The treatment inhibits Mls-1a allo-antigen-specific expansion of CD4+ non-Tregs expressing Vβ6 TCR subfamily but leaves the expansion of Vβ6-expressing Tregs unaffected, allowing the latter to selectively expand and establish donor-specific tolerance. Furthermore, anti-CD4 mAb inhibits in vitro the selective expansion of allo-antigen-specific CD4+ non-Tregs but not natural Tregs, as observed with in vitro anti-CD154 [CD40 ligand (CD40L)] mAb or rapamycin treatment. The results collectively indicate that the differential effect of biologicals and pharmacological substances on the expansion of allo-antigen-specific Tregs and effector T cells and resulting dominance of the former can be a key general mechanism underlying dominant transplantation tolerance.
32
Kensuke Inaba, Muneo Inaba, Nikolaus Romani et al. · The Journal of Experimental Medicine · 1992 · 3.8K citations · Full text
CTLA-4 Control over Foxp3 <sup>+</sup> Regulatory T Cell Function
Kajsa Wing, Yasushi Onishi, Paz Prieto-Martin et al. · Science · 2008 · 2.9K citations
Takamune Takahashi, Yuhshi Kuniyasu, Masaaki Toda et al. · International Immunology · 1998 · 1.5K citations · Full text
Life Sciences, Immunology, Pathology +17